null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

H8 Biosimilar (5T4) Antibody (HDBS0137)

SKU HDBS0137
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein 5T4
Reactivity Human
Host Species Humanized
Isotype IgG1
€431
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

H8 Biosimilar (5T4) Antibody (HDBS0137)

The H8 Biosimilar 5T4 Antibody is a recombinant monoclonal antibody designed for research involving 5T4, a cell surface antigen associated with tumor growth and metastasis. The antibody, developed using cutting-edge biosimilar technology, is highly specific and exhibits potent anti-tumor activity in preclinical studies.5T4 is a promising target for cancer therapy due to its overexpression in a wide range of solid tumors, making it a potential biomarker for diagnosis and targeted treatment.

The H8 Antibody binds specifically to the 5T4 antigen, blocking its function and inhibiting tumor cell proliferation and migration.This biosimilar antibody offers a novel approach to cancer therapy, with the potential to improve treatment outcomes and reduce side effects compared to traditional chemotherapy. Its unique mechanism of action and high specificity make it a valuable tool for studying tumor biology and developing personalized treatment strategies for cancer patients.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose